PATIENTS WITH IPSS-R INTERMEDIATE RISK CAN BE SEPARATED INTO THREE RISK GROUPS

Nachtkamp, K; Reykowski, T; Hildebrandt, B; Baldus, S; Rudelius, M; Neukirchen, J; Kundgen, A; Strupp, C; Schroeder, T; Haas, R; Germing, U

LEUKEMIA RESEARCH, 2017; 55 ( ): S147